Multibic (Sodium Hydrogen Carbonate, Magnesium Chloride Hexahydrate, Potassium Chloride, Sodium Chloride, Calc)

Sodium hydrogen carbonate (bicarbonate) acts as a buffering agent. When infused, it combines with hydrogen ions to form carbonic acid, which quickly dissociates to water and carbon dioxide. This process helps correct metabolic acidosis that can occur during dialysis, supporting normal blood pH while also contributing sodium to the overall electrolyte composition.

The prescribed dose of Multibic is set by the treating clinician based on the patient’s individual electrolyte profile, fluid status, type of dialysis modality and overall clinical condition. Laboratory values such as serum sodium, potassium, magnesium and calcium guide the volume and rate of infusion to achieve the desired balance.

Safety data for Multibic in pregnancy and lactation are limited. Because it contains multiple electrolytes that can affect maternal and fetal fluid balance, it should only be used when clearly indicated and prescribed by a healthcare professional familiar with the risks and benefits for the mother and the unborn or nursing child.

To order Multibic, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if required) and any necessary import documentation.

Standard dialysis fluids often contain a fixed electrolyte composition, whereas Multibic offers a customizable blend of sodium, potassium, magnesium, calcium and chloride, allowing clinicians to tailor therapy to individual patient needs. Its inclusion of bicarbonate provides additional buffering capacity, which can be advantageous in managing metabolic acidosis during treatment.

Multibic should be stored at ambient temperature, preferably below 25 °C. Keep the solution in its original, sealed container, protect it from direct sunlight and moisture, and avoid freezing. Follow any additional handling instructions on the label to maintain sterility and solution integrity.

Multibic is supplied as a sterile solution for injection. It can be added to the dialysis circuit as a dialysate component or infused intravenously through a controlled infusion set. Administration is performed by qualified healthcare personnel, who set the appropriate flow rate and monitor the patient’s vital signs and electrolyte levels throughout the procedure.

The most serious risks include severe electrolyte disturbances such as hyperkalemia or hypermagnesemia, which can lead to cardiac arrhythmias, and rare anaphylactic reactions. Prompt monitoring of serum electrolytes and patient observation during infusion are essential to detect and manage these potentially life‑threatening events.

Multibic should be avoided in patients with known hypersensitivity to any of its components, in those with uncontrolled hyperkalemia or hypermagnesemia, and in individuals for whom rapid shifts in fluid or electrolyte balance could exacerbate cardiac or neurological conditions. Clinicians must evaluate each patient’s medical history before initiating therapy.